Table 1. Summary of clinical and pathological features and group differences between papillary renal cell carcinoma (pRCC) and clear cell renal cell carcinoma (ccRCC) (whole cohort, n = 7,543).
pRCC | ccRCC | whole cohort | |||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | p | |
Age at surgery | 0.94 | ||||||
<65 years | 1,096 | 56.4 | 3,166 | 56.5 | 4,262 | 56.5 | |
≥65 years | 847 | 43.6 | 2,434 | 43.5 | 3,281 | 43.5 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 | |
Sex | <0.001 | ||||||
Female | 474 | 24.4 | 2,243 | 40.0 | 2,717 | 36.0 | |
Male | 1,469 | 75.6 | 3,357 | 60.0 | 4,826 | 64.0 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 | |
T classification | <0.001 | ||||||
pT1a | 862 | 44.4 | 1,854 | 33.1 | 2,716 | 36.0 | |
pT1b | 433 | 22.3 | 1,347 | 24.1 | 1,780 | 23.6 | |
pT2a | 163 | 8.4 | 397 | 7.1 | 560 | 7.4 | |
pT2b | 82 | 4.2 | 134 | 2.4 | 216 | 2.9 | |
pT3a | 288 | 14.8 | 1,125 | 20.1 | 1,413 | 18.7 | |
pT3b | 75 | 3.9 | 604 | 10.8 | 679 | 9.0 | |
pT3c | 8 | 0.4 | 36 | 0.6 | 44 | 0.6 | |
pT4 | 32 | 1.6 | 103 | 1.8 | 135 | 1.8 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 | |
Grade | 0.0021 | ||||||
G1 | 279 | 14.4 | 938 | 16.8 | 1,217 | 16.1 | |
G2 | 1,248 | 64.2 | 3,324 | 59.4 | 4,572 | 60.6 | |
G3 | 358 | 18.4 | 1,145 | 20.4 | 1,503 | 19.9 | |
G4 | 58 | 3.0 | 193 | 3.4 | 251 | 3.3 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 | |
Lymph node metastasis | <0.001 | ||||||
pN0/pNx | 1,800 | 92.6 | 5,390 | 96.2 | 7,190 | 95.3 | |
pN+ | 143 | 7.4 | 210 | 3.8 | 353 | 4.7 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 | |
Distant metastasis | 0.02 | ||||||
cM0 | 1,792 | 92.2 | 5,060 | 90.4 | 6,852 | 90.8 | |
cM1 | 151 | 7.8 | 540 | 9.6 | 691 | 9.2 | |
All | 1,943 | 100.0 | 5,600 | 100.0 | 7,543 | 100.0 |